← Leaderboards
Rihe Liu
University Of North Carolina Chapel Hill
$10,529,623
Attributed
$13,118,755
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,118,755 · 11
By mechanism
R01$6,243,973 · 4
U01$2,808,777 · 1
U54$2,309,273 · 2
R21$1,756,732 · 4
Top collaborators
- Tatiana K Bronich5 shared
- Alexander V Kabanov5 shared
- John E Sondek4 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Joseph M Desimone$16,962,164
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsBaseSpecificityLibrariesTumorNanoparticleSelf AssemblyMalignant NeoplasmsInterestTechnologyErbb2 GeneSurfaceReceptorLigandsAffinityMessenger RnaEngineeringEpidermal Growth Factor ReceptorPeptidesBinding (Molecular Function)NanotechnologyMouse ModelTargeted DeliveryIn Vivo
Grant awards (42)
A Wholly Protein-based Self-assembly Nanoplatform for TNBC-specific Combination Therapy$473,654
R01 · FY2025 · EB · contact PI
A Wholly Protein-based Self-assembly Nanoplatform for TNBC-specific Combination Therapy$464,182
R01 · FY2024 · EB · contact PI
A Wholly Protein-based Self-assembly Nanoplatform for TNBC-specific Combination Therapy$473,654
R01 · FY2023 · EB · contact PI
A Wholly Protein-based Self-assembly Nanoplatform for TNBC-specific Combination Therapy$473,654
R01 · FY2022 · EB · contact PI
Trimerization of the N-terminal Domain of ACE2 for Bifunctional Trapping of Future SARS-CoV-2 Variants$194,375
R21 · FY2022 · AI · contact PI
Trimerization of the N-terminal Domain of ACE2 for Bifunctional Trapping of Future SARS-CoV-2 Variants$224,925
R21 · FY2021 · AI · contact PI
Targeted Core Shell Nanogels for Triple Negative Breast Cancer$545,618
U01 · FY2019 · CA
Inhibition of GTPases and G proteins to treat human disease$358,307
R01 · FY2019 · GM
Targeted Core Shell Nanogels for Triple Negative Breast Cancer$562,533
U01 · FY2018 · CA
Inhibition of GTPases and G proteins to treat human disease$358,307
R01 · FY2018 · GM
Targeted Core Shell Nanogels for Triple Negative Breast Cancer$562,542
U01 · FY2017 · CA
Inhibition of GTPases and G proteins to treat human disease$358,307
R01 · FY2017 · GM
Targeted Core Shell Nanogels for Triple Negative Breast Cancer$562,542
U01 · FY2016 · CA
Inhibition of GTPases and G proteins to treat human disease$358,307
R01 · FY2016 · GM
Novel Single Domain Antibodies with Multivalency and Multispecificity$305,673
R01 · FY2016 · CA · contact PI
Targeted Core Shell Nanogels for Triple Negative Breast Cancer$575,542
U01 · FY2015 · CA
Novel Single Domain Antibodies with Multivalency and Multispecificity$305,715
R01 · FY2015 · CA · contact PI
Novel Single Domain Antibodies with Multivalency and Multispecificity$296,583
R01 · FY2014 · CA · contact PI
Targeting Ligand Core$77,073
U54 · FY2014 · CA · contact PI
Novel Single Domain Antibodies with Multivalency and Multispecificity$287,437
R01 · FY2013 · CA · contact PI
Targeting Ligand Core$74,296
U54 · FY2013 · CA · contact PI
Novel Single Domain Antibodies with Multivalency and Multispecificity$305,832
R01 · FY2012 · CA · contact PI
Novel Anti-allergic Single-domain Antibody Against IgE$182,324
R21 · FY2012 · AI · contact PI
Targeting Ligand Core$79,460
U54 · FY2012 · CA · contact PI
Novel Anti-allergic Single-domain Antibody Against IgE$219,402
R21 · FY2011 · AI · contact PI
Targeting Ligand Core$79,459
U54 · FY2011 · CA · contact PI
Targeting Ligand Core$81,915
U54 · FY2010 · CA · contact PI
Combinatorial Library Screening Core$457,370
U54 · FY2009 · CA · contact PI
Identification of the Interactome of Methylated Histones from Human Proteome$293,720
R21 · FY2009 · DA · contact PI
Identification of the Interactome of Methylated Histones from Human Proteome$59,950
R21 · FY2009 · DA · contact PI
Combinatorial Library Screening Core$433,439
U54 · FY2008 · CA · contact PI
Identification of the Interactome of Methylated Histones from Human Proteome$292,890
R21 · FY2008 · DA · contact PI
Identification of Caspase Substrates from Human Proteome$278,680
R01 · FY2008 · NS · contact PI
Combinatorial Library Screening Core$425,854
U54 · FY2007 · CA · contact PI
Identification of Caspase Substrates from Human Proteome$278,680
R01 · FY2007 · NS · contact PI
Combinatorial Library Screening Core$300,849
U54 · FY2006 · CA · contact PI
Identification of Caspase Substrates from Human Proteome$287,003
R01 · FY2006 · NS · contact PI
Combinatorial Library Screening Core$299,558
U54 · FY2005 · CA
Identification of Caspase Substrates from Human Proteome$286,089
R01 · FY2005 · NS
Identifying Calpain-10 Substrates from Human Proteome$144,573
R21 · FY2005 · DK
Identification of Caspase Substrates from Human Proteome$293,909
R01 · FY2004 · NS
Identifying Calpain-10 Substrates from Human Proteome$144,573
R21 · FY2004 · DK